The Valley Desk

ArticleHaematologicaPublished

Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name GSK, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Haematologica
Published
Subject terms
Killer Cells, Natural; Humans; Multiple Myeloma; Female; Male; B-Cell Maturation Antigen; Antibodies, Monoclonal, Humanized
PubMed ID
40874339
PubMed Central ID
PMC12862312
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal